SCOPE 2018

PCI to acquire Australia-based clinical trial services company

By Melissa Fassbender contact

- Last updated on GMT

(Image: PCI Pharma Services)
(Image: PCI Pharma Services)

Related tags: Pci pharma services, Pharmacology, Clinical trial

PCI Pharma Services (PCI) has announced its intent to acquire Pharmaceutical Packaging Professionals (PPP) as the company focuses on growth and rapid expansion.

The acquisition – PCI’s fifth outside the US in five years – enables it to better support customers from early phases of clinical development to commercial launch, according to the pharmaceutical outsourcing services provider

Melbourne, Australia-based PPP has a focus on early phase development, with services including early clinical phase sterile and non-sterile drug manufacture, packaging and labeling, in addition to logistical services such storage and distribution.

There’s a lot of Phase I activity in Australia​,” Justin Schroeder, senior executive director, Global Marketing and Design, PCI, told us at the SCOPE Summit this week in Orland, FL, adding that PPP’s services are complementary to PCI's portfolio of clinical and commercial services.

Additionally, access to the Asia Pacific region expands PCI’s footprint in that area, which is a growing part of the clinical trial community for regional investigational site activity, he added.

PCI plans to fully integrate PPP under the PCI pharma Services brand, Schroeder explained. “We anticipate we’ll retain all of the positions​,” he said.

Schroeder added the company is “really focused on growth​” and expects “rapid expansion​.”

Currently, PPP is expanding one of its facilities to up its storage and distribution services and add labeling and packaging rooms, Grade D manufacturing, and sterile-fill manufacturing capabilities for Phase II clinical studies.

In October of 2017, PCI acquired the pharmaceutical and healthcare contract packaging services provider Millmount Healthcare based in Dublin, Ireland. The company has also been investing in site expansions at its US and UK-based locations.

Related news

Show more

Related products

show more

Import Risks & Clinical Supply Depots

Import Risks & Clinical Supply Depots

Catalent Pharma Solutions | 07-Nov-2018 | Case Study

A sponsor running a clinical trial in Israel arranged to ship their clinical trial product from Europe to a depot in Israel. With the protocol based in...

Discover Fermion’s new API unit 4 in Hanko

Discover Fermion’s new API unit 4 in Hanko

Recorded the 04-Sep-2018 | Webinar

Join this webinar to learn more about Fermion’s new manufacturing unit 4 at the Hanko site. This webinar will provide virtual tour to our new state of...

Related suppliers

Follow us

Products

View more

Webinars